| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10885803 | Drug Discovery Today | 2015 | 6 Pages |
Abstract
- The future of pharmaceutical discovery is unclear in light of unique trends in marketing and R&D allocations.
- Slowing investment in early-stage discovery raises concerns about pipeline sustainability.
- Decreasing NIH funding threatens the future of academia as a source of innovation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Michael S. Kinch, Denton Hoyer,